Dr. Ana I. Tergas

Surgical Oncology
City Of Hope's Helford Clinical Research Hospital
1500 Duarte Rd, 
Duarte, CA 
Accepting New Patients
City Of Hope's Helford Clinical Research Hospital
1500 Duarte Rd, 
Duarte, CA 

Overview

Ana Tergas is a Surgical Oncologist practicing medicine in Duarte, California.

Her clinical expertise encompasses Adult Soft Tissue Sarcoma, BRCA Positive Breast Cancer, HER2 Negative Breast Cancer, Endoscopy, and Vulvectomy.

She is actively involved in clinical research, co-authoring 165 peer reviewed articles and participating in 2 clinical trials. Dr. Tergas is currently accepting new patients.

Specialties

Surgical Oncology

Licenses

Obstetrics & Gynecology in CA

Hospital Affiliations

The University Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 1 Less Insurance Carrier -

Locations

City of Hope's Helford Clinical Research Hospital
1500 Duarte Rd, Duarte, CA 91010

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2, Randomized, Open Label, Efficacy Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™ 2000 Alone or in Combination With Imiquimod, for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Vulva
A Phase 2, Randomized, Open Label, Efficacy Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™ 2000 Alone or in Combination With Imiquimod, for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Vulva
Enrollment Status: Completed
Publish Date: August 25, 2023
Intervention Type: Biological, Drug, Device
Study Drugs: VGX-3100, Imiquimod Cream
Study Phase: Phase 2
A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™-5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix
A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™-5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix
Enrollment Status: Completed
Publish Date: July 27, 2023
Intervention Type: Biological, Device
Study Drug: VGX-3100
Study Phase: Phase 3
View 1 Less Clinical Trial

164 Total Publications

Return to homeland: Bereaved caregiver perceptions of immigrant patient quality of death after repatriation to their country of origin, a retrospective cohort study.
Return to homeland: Bereaved caregiver perceptions of immigrant patient quality of death after repatriation to their country of origin, a retrospective cohort study.
Journal: Palliative & supportive care
Published: June 05, 2026

Frequently Asked Questions about Dr. Ana I. Tergas

How do I make an appointment with Dr. Ana I. Tergas?

You can book an appointment with Dr. Ana I. Tergas by calling their office at 866-461-6206. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ana I. Tergas a top-rated expert for Endoscopy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ana I. Tergas is classified as an Experienced expert for Endoscopy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ana I. Tergas specialize in?

While Dr. Ana I. Tergas is a Surgical Oncology, they have specific expertise in Endoscopy, Adult Soft Tissue Sarcoma, and Vulvectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Surgical Oncology.

Does Dr. Ana I. Tergas participate in research or clinical trials?

Yes. Dr. Ana I. Tergas has published 164 articles and abstracts on conditions like Endoscopy. You can view a list of Dr. Ana I. Tergas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ana I. Tergas accept my insurance?

Dr. Ana I. Tergas accepts most major insurance plans, including Anthem BCBS and Cigna. We recommend calling the office directly at 866-461-6206 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tergas's expertise for a condition
ConditionClose
        View All 12 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile